About
Maplight Therapeutics, Inc. Common Stock (NASDAQ:MPLT) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 26 2026
MapLight Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Mar 2 2026
MapLight Therapeutics to Participate in Upcoming Investor Conferences
Jan 9 2026
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026
Jan 5 2026
MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer’s Disease Psychosis
Dec 16 2025
SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies
Financials
Revenue
$0
Market Cap
$960.55 M
EPS
-18.56
Google Übersetzer